READ-ONLY DIGITIZATION RESULT
COMPEL: osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC and progression on first-line osimertinib.
ESMO Open · 2025-Oct · PMID 41139117
Panel Progression-free_survival_PFS_提取失败待 EXE 对齐验证
Progression-free survival (PFS)
Figure 1 Kaplan–Meier curve of progression-free survival (PFS) (full analysis set). Data cut-off: 28 October 2024. The crosses indicate censored observations. Progression events that did not occur within two missed visits of the last evaluable assessment were censored. The hazard ratio (HR) and confidence interval (CI) were calculated using a log-rank test.
算法:legacy-0.5.0引擎:enhanced-linux
No curves extracted
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | failed | 待验证 | 0 | 2026-07-23T17:13:59+00:00 |